Citadel Advisors’s Pasithea Therapeutics Corp. Warrants KTTAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$335 Buy
+15,511
New +$335 ﹤0.01% 5748
2024
Q3
Sell
-13,189
Closed -$144 6289
2024
Q2
$144 Sell
13,189
-15
-0.1% ﹤0.01% 5796
2024
Q1
$162 Buy
13,204
+100
+0.8% +$1 ﹤0.01% 6009
2023
Q4
$236 Buy
13,104
+278
+2% +$5 ﹤0.01% 5784
2023
Q3
$190 Buy
+12,826
New +$190 ﹤0.01% 5784